ArticleBreast cancer research and treatment2023

Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy.

Lubna N Chaudhary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.